Articles From: Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum to Alfa Laval Gets SEK240 Million Pumps Order


Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that Chairman John W.
Sign-up for Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its partner GlaxoSmithKline (GSK) plc has announced global revenue for Promacta™/Revolade™ for the second quarter ended June 30, 2014 of $92 million, up 31% from the second quarter of 2013.
Sign-up for Ligand Partner GSK Announces Record Quarterly Promacta™/Revolade™ Revenue of $92 Million investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported that total revenues for the second quarter of 2014 are expected to be approximately $10.6 million.
Sign-up for Ligand Reports Second Quarter Revenues and Announces Share Repurchase Program investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (GSK) plc has received approval of a supplemental New Drug Application (sNDA) for the once-daily use of Promacta ® /Revolade ™ (eltrombopag) in patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST). 1 SAA is a blood disorder where the bone marrow fails to make enough red blood cells, white blood cells and platelets.
Sign-up for Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta®/Revolade™ For Use in Patients with Severe Aplastic Anemia investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that its partner Sage Therapeutics Inc., a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation to the SAGE-547 development program.
Sign-up for Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and six months ended June 30, 2014, and provided an operating forecast and program updates.
Sign-up for Ligand Reports Second Quarter 2014 Financial Results investment picks
2014/8/20
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1139079&ProfileId=051205&sourceType=1 TAMPA, FL --
Sign-up for Enviro-Serv, Inc. Announces Target Acquisition Update and Second Dividend Strategy investment picks
2014/7/15
ProPay ® , a TSYS ® company , announced today a partnership with ThreatMetrix ® to provide advanced fraud prevention solutions to its customers.
Sign-up for ProPay® Launches TSYS Guardian CyberShieldSM in Partnership with ThreatMetrix® to Provide Advanced Fraud Prevention Solutions investment picks
2014/7/9
The Vitamin Shoppe Asks Its Dietary Supplement Vendors to Submit Product Labels to National Institutes of Health Dietary Supplement Label Database NORTH BERGEN, N.J. , July 9, 2014 /PRNewswire/ -- The Vitamin Shoppe ® , a leading health and wellness retailer, is at the forefront of product ingredient transparency for dietary supplements.
Sign-up for The Vitamin Shoppe Works with Vendors to Encourage Product ingredient Transparency investment picks
2014/7/8
NEW YORK, July 8, 2014 (GLOBE NEWSWIRE) -- NASDAQ OMX today announced that AdvisorShares, Bethesda, MD.-based sponsor of actively managed exchange traded funds (ETFs) will launch a new ETF on Wednesday, July 9, 2014.
Sign-up for NASDAQ OMX Lists AdvisorShares Sunrise Global Multi-Strategy ETF (Symbol: MULT) investment picks
2014/7/22
Modulus LLC , a Progress company and a leading provider of Node.js hosting and MongoDB, today announced that it is has released a new set of add-ons as part of its add-on marketplace.
Sign-up for Modulus Introduces Add-On Marketplace for Enhanced Node.js_Developer Experience investment picks
Actuate Corporation (NASDAQ:BIRT), The BIRT Company™ and the leader in personalized analytics and insights, today announced an alliance with Versiant Corporation, a leading provider of IT professional services and marine terminal solutions support.
Sign-up for REPEAT/Actuate and Versiant Introduce a Fully Enabled Data Integration Solution for the Marine Terminal Industry investment picks
Actuate Corporation (NASDAQ:BIRT), The BIRT Company™ and the leader in personalized analytics and insights, today announced an alliance with Versiant Corporation, a leading provider of IT professional services and marine terminal solutions support.
Sign-up for Actuate and Versiant Introduce a Fully Enabled Data Integration Solution for the Marine Terminal Industry investment picks
Announces New Innovations that Set the Standard for Performance, Reliability, Capacity, Agility and Efficiency for Helping Companies Harness the Power of Data - Introduces industry's first server-side Flash clustering and volume management software to transform performance computing and extend leadership of Flash fabric solutions portfolio - Now shipping 8TB HelioSeal™ platform HDDs and areal density leading, air-based 6TB HDDs; Targets Helium ubiquity by 2017 and defines path to 10TB HDD - Announces new NVMe-compliant PCIe SSDs that enable the next wave of application acceleration with unmatched performance and density - Addresses emerging active archive demand with new storage platform that aims to deliver most cost effective, power efficient and highest density solutions for petabyte-scale data centers SAN FRANCISCO , Sept.
Sign-up for HGST Unveils Intelligent, Dynamic Storage Solutions To Transform The Data Center investment picks
The Hershey Company (NYSE: HSY): Ivory Coast cocoa farmers learning modern agricultural farming practices through Hershey’s Learn to Grow program.
Sign-up for Hershey Expands Learn to Grow Program in Ivory Coast to Benefit 10,000 Cocoa Farmers and Improve Communities investment picks
Industry's first deployment of converged edge router in Japan TOKYO , July 30, 2014 /PRNewswire/ -- ARRIS Group, Inc. (Nasdaq: ARRS) today announced that Izukyu Cable has selected the ARRIS E6000™ Converged Edge Router (CER) to enhance its high-speed broadband services.
Sign-up for Japan's Izukyu Cable Selects ARRIS E6000™ Converged Edge Router investment picks
New Media Institute (NMI) has awarded a Standard of Excellence honor to the North Carolina Lien Agent System (LiensNC) website, http://liensnc.com .
Sign-up for LiensNC.com Wins 2014 Standard of Excellence Award investment picks
HOQUIAM, Wash., July 22, 2014 (GLOBE NEWSWIRE) -- Timberland Bancorp, Inc. (Nasdaq:TSBK) ("Timberland" or "the Company") today reported net income to common shareholders of $1.43 million, or $0.20 per diluted common share for the quarter ended June 30, 2014.
Sign-up for Timberland Bancorp EPS Increases 100% to $0.20 for Third Fiscal Quarter of 2014; Increases Cash Dividend 25% to $0.05 Per Share investment picks
By Dominic Chopping and Alex MacDonald STOCKHOLM --
Sign-up for Meda to buy drugs maker Rottapharm for $3.08 billion investment picks
2014/8/27
By Dominic Chopping Danish insulin maker Novo Nordisk A/S (NOVO-B.KO) has bought a manufacturing facility in West Lebanon, New Hampshire, U.S. from Olympus Biotech, it said Wednesday.
Sign-up for Novo Nordisk Buys US Manufacturing Plant investment picks
2014/9/2
By Dominic Chopping Finnish utility Fortum Oyj (FUM1V.HE) said Tuesday that the Board of Adjustment of the Large Taxpayers' Office has on 21 August 2014 unanimously approved Fortum's appeal for the tax assessment imposed for the year 2007.
Sign-up for Fortum Wins Appeal Against Belgian Tax Charges investment picks
2014/9/1
By Dominic Chopping Finnish utility Fortum Oyj (FUM1V.HE) said Monday it has bought a 13.6% stake in Finnish wave energy developer Wello Oy.
Sign-up for Fortum Buys Stake in Wave Energy Developer investment picks
2014/9/15
By Dominic Chopping Norway's Aker Solutions ASA (AKSO.OS) said Monday its Aker Oilfield Services (AKOFS) unit has been awarded a five-year $465 million contract from Petrobras (PBR) to provide subsea intervention services offshore Brazil.
Sign-up for Aker Solutions Gets $465 Million Contract Offshore Brazil investment picks
2014/9/4
By Dominic Chopping Norwegian oil and gas major Statoil ASA (STO) said Thursday that it has completed drilling two wells, with the Martin well in the US Gulf of Mexico not considered a commerical discovery, while the Dilolo well in the Kwanza basin in Angola didn't encounter hydrocarbons.
Sign-up for Statoil Announces Non-Commercial Discovery in Gulf of Mexico investment picks
2014/9/2
By Dominic Chopping Norwegian oil and gas major Statoil ASA (STO) has entered an agreement with industry adviser DNV GL as they look to establish an international industry standard for subsea process technology.
Sign-up for Statoil and DNV GL in Subsea Technology Project investment picks
2014/8/29
By Dominic Chopping Norwegian oil company Det Norske Oljeselskap ASA (DETNOR.OS) said Friday that wildcat well 2/9-5S on the Heimdalsho prospect offshore Norway is dry.
Sign-up for Det Norske Oljeselskap: Dry Well on Heimdalsho Prospect, Offshore Norway investment picks
2014/9/2
By Dominic Chopping Novo Nordisk A/S (NVO) is to discontinue its activities within inflammatory disorders after deciding to increase efforts within diabetes prevention and treatment, obesity and diabetes complications, it said Tuesday.
Sign-up for Novo Nordisk Stops Inflammatory Disease Research investment picks
2014/9/10
By Dominic Chopping Statoil ASA (STO) said Wednesday that the Fram H-North and Svalin C fields in the North Sea have now started producing.
Sign-up for Statoil Starts Production From North Sea Fields Fram H-North and Svalin C investment picks
2014/8/27
By Dominic Chopping STOCKHOLM--Alfa Laval (ALFA.SK), the Swedish maker of heat exchangers and separators, said Wednesday it has been awarded a SEK240 million order to supply pumping systems to Samsung Heavy Industries (010140.SE) in South Korea.
Sign-up for Alfa Laval Gets SEK240 Million Pumps Order investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum to Alfa Laval Gets SEK240 Million Pumps Order
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices